Sequoia Consulting Group, LLC
Sequoia Consulting Group, LLC is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Sequoia Consulting Group, LLC.
Sequoia Consulting Group, LLC is a company.
Key people at Sequoia Consulting Group, LLC.
Key people at Sequoia Consulting Group, LLC.
Sequoia Consulting Group, LLC is a San Diego, California-based life sciences consulting firm founded in 2013, specializing in technical, quality, scientific operations, business transformation, and program/project management for biotech, pharma, diagnostics, and medical device companies.[1] It supports clients across the full product lifecycle, from R&D to commercial operations, with highly experienced consultants who assist in executing objectives for early-stage and established firms.[1] The company was acquired by Hexagon Capital Alliance, a middle-market investment banking firm, enhancing its strategic positioning in the life sciences sector.[1]
Note: Multiple entities share similar names, including a larger HR/benefits firm (Sequoia at sequoia.com, founded ~2001, with 24+ years in total compensation, benefits, and risk management)[2][4][5] and an energy consulting group (since 1989, focused on supply chain and engineering).[3] This profile focuses on the life sciences LLC per the query's specificity.[1]
Sequoia Consulting Group, LLC was founded in 2013 by Brandy Bullen in San Diego, emerging from the incubator of its financial backer, Bootstrap Venture Partners.[1] Bullen leveraged her expertise to build a team of subject matter experts in life sciences, positioning the firm to go beyond advisory roles by aiding in project execution.[1] Early growth centered on serving blue-chip clients in biotech and pharma, with a focus on increasing successful outcomes through hands-on support.[1] The firm's acquisition by Hexagon Capital Alliance (formerly Moss Adams Capital, rebranded 2021) marked a pivotal evolution, integrating it into a network with 120+ years of middle-market experience across 300+ transactions in healthcare and related sectors.[1]
Sequoia rides the wave of booming life sciences innovation, fueled by advances in biotech, personalized medicine, and medtech amid post-pandemic R&D acceleration and regulatory pressures.[1] Its timing aligns with surging demand for specialized consulting as startups scale amid funding crunches and big pharma seeks agile partners for pipeline acceleration.[1] Market forces like talent shortages in quality/compliance and complex supply chains favor its execution-oriented model, while the Hexagon acquisition amplifies influence via deal-making networks in healthcare M&A.[1] In the tech-adjacent life sciences ecosystem, it influences by de-risking development, enabling faster market entry for diagnostics and devices that integrate AI/data analytics.
Sequoia Consulting Group, LLC is poised for expanded reach post-acquisition, likely targeting more M&A-driven growth in life sciences as biotech funding rebounds and global supply chains stabilize.[1] Trends like AI-enabled drug discovery, precision diagnostics, and regulatory harmonization will shape its trajectory, amplifying demand for its full-lifecycle expertise.[1] Its influence may evolve toward integrated advisory in consolidated markets, solidifying its niche as the execution partner that turns life sciences ambition into outcomes—echoing its founding promise of beyond-traditional impact.[1]
